Case report of cholesterol crystal embolism caused by rivaroxaban tablets
10.13699/j.cnki.1001-6821.2023.23.030
- VernacularTitle:利伐沙班片致胆固醇结晶栓塞的病例分析
- Author:
Rui-Juan LI
1
;
Qian XIANG
;
Yi-Min CUI
Author Information
1. 北京大学第一医院药学部,北京 100034;山西白求恩医院、山西医学科学院同济山西医院、山西医科大学第三医院药学部,山西太原,030032;华中科技大学同济医学院附属同济医院药学部,湖北武汉 430030
- Keywords:
rivaroxaban;
anticoagulant;
cholesterol crystal embolism
- From:
The Chinese Journal of Clinical Pharmacology
2023;39(23):3482-3485
- CountryChina
- Language:Chinese
-
Abstract:
Through the analysis of a case of cholesterol crystal embolism(CCE)suspected to be caused by rivaroxaban tablets,it is suggested that clinical pharmacists should be alert to the occurrence of CCE when using anticoagulant drugs such as rivaroxaban in the clinical treatment of patients with atherosclerosis disease,especially for patients with high risk factors(such as smoking,hypercholesterolemia,hypertension,obesity and diabetes)of CCE.Before taking medication,clinical pharmacists should inquire about patients'current medical history and past medication history,and conduct a risk assessment.In case of CCE,timely treatment and curative care are needed.
